Sage Journals: Discover world-class research

Open access

Research article

First published 2024

A non-inferiority,phase III trial of gemcitabine plus capecitabine versus gemcitabine plus carboplatin as first-line therapy and tumor-infiltrating lymphocytes as a prognostic biomarker in patients with advanced triple-negative breast cancer

Xiaodong Liu, Weipeng Zhao, Yongsheng Jia [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2010-09

Metastatic Pancreatic Cancer Response to Treatment with Cetuximab and Gemcitabine plus Capecitabine: A Case Report and Review of the Literature

Mei Li, Ming Jiang, Xi Yan [...]

Tumori Journal

Open access

Research article

First published 2022

Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma

Sora Kang, Changhoon Yoo, So Heun Lee [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2014-11

Retreatment with Trastuzumab after Progression on Lapatinib-Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer: A Single-Institution Experience

Paolo Carli, Loredana Militello, Gian Maria Miolo [...]

Tumori Journal

Open access

Research article

First published 2025

Retrospective analysis of capecitabine maintenance therapy in pancreatic ductal adenocarcinoma

Jordan Powell, Alexa F. Viniotis, Chase Irwin [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2016-6

Itraconazole therapy in a pancreatic adenocarcinoma patient: A case report

Nicholas R Lockhart, James Aubrey Waddell, Nathan Eric Schrock

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2007-03

Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model

Jenifer M. Saucier, Jiang Yu, Anjali Gaikwad [...]

Journal of Oncology Pharmacy Practice

Search results

A non-inferiority,phase III trial of gemcitabine plus capecitabine versus gemcitabine plus carboplatin as first-line therapy and tumor-infiltrating lymphocytes as a prognostic biomarker in patients with advanced triple-negative breast cancer

Metastatic Pancreatic Cancer Response to Treatment with Cetuximab and Gemcitabine plus Capecitabine: A Case Report and Review of the Literature

Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma

Retreatment with Trastuzumab after Progression on Lapatinib-Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer: A Single-Institution Experience

Retrospective analysis of capecitabine maintenance therapy in pancreatic ductal adenocarcinoma

Itraconazole therapy in a pancreatic adenocarcinoma patient: A case report

Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model